Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 270930 | https://doi.org/10.1155/2014/270930

QingQing Hao, Xu Chen, XiaoYu Wang, Bo Dong, ChuanHua Yang, "Curcumin Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm by Inhibition of Inflammatory Response and ERK Signaling Pathways", Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 270930, 10 pages, 2014. https://doi.org/10.1155/2014/270930

Curcumin Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm by Inhibition of Inflammatory Response and ERK Signaling Pathways

Academic Editor: Mohamed Eddouks
Received06 Aug 2014
Revised12 Oct 2014
Accepted13 Oct 2014
Published06 Nov 2014


Background and Objectives. Curcumin has long been used to treat age-related diseases, such as atherosclerosis and coronary heart disease. In this study, we explored the effects of curcumin on the development of abdominal aortic aneurysm (AAA). Methods. ApoE−/− mice were randomly divided into 3 groups: AngII group, AngII + curcumin (AngII + Cur) group (100 mg/kg/d), and the control group. Miniosmotic pumps were implanted subcutaneously in ApoE−/− mice to deliver AngII for 28 days. After 4-week treatment, abdominal aortas with AAA were obtained for H&E staining, immunohistochemistry, and Western blotting. Results. The results showed that curcumin treatment significantly decreased the occurrence of AAA. The levels of macrophage infiltration, monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factors-α (TNF-α) were significantly lower in AngII + Cur group than those in AngII group (all ). The level of superoxide dismutase (SOD) was significantly higher in AngII + Cur group than those in AngII group . The ERK1/2 phosphorylation in AngII + Cur group was significantly lower than that in AngII group . Conclusions. These results suggested that curcumin can inhibit the AngII-induced AAA in ApoE−/− mice, whose mechanisms include the curcumin anti-inflammation, antioxidative stress, and downregulation of ERK signaling pathway.

1. Introduction

Abdominal aortic aneurysm (AAA) is a severe disease threatening the human health and often causes death by rupture. The main pathological process of AAA includes (1) increasing inflammatory response, especially the macrophage infiltration and monocyte chemoattractant protein-1 (MCP-1) expression, (2) activating matrix metalloproteinases (MMP) and depredating extracellular matrix, and (3) degeneration of vascular media and damaging or breaking of elastic fiber [1, 2]. It is documented that statins, angiotensin receptor blockers (ARB), tissue inhibitors of metalloproteinases (TIMP), and some traditional Chinese medicines are beneficial for the treatment of AAA. However, no specific medicine can cure the disease. At present, the surgery is the only effective treatment method for AAA.

Recent studies have demonstrated that the renin-angiotensin system (RAS), especially angiotensin II (AngII), plays an important role in the pathogenesis of atherosclerosis and AAA. Lu et al. reported that subcutaneous infusion of AngII increases the size of atherosclerotic plaque and AAA formation in apoE-deficient mice (ApoE−/− mice), suggesting that the imbalance of RAS is involved in the pathogenesis of AAA [3]. The AngII-induced aneurysm formation in ApoE−/− mice mirrors many characteristics of the human AAA, such as increase of inflammatory response, enhancement of MMP activity, depredation of extracellular matrix, and rupture of aortic elastic layer. Furthermore, these studies showed that inhibition of RAS activation prevented AAA formation [3, 4]. Daugherty’s group demonstrated that the AT1 receptor antagonist, losartan, prevented the formation of AAA and AT2 receptor antagonist, PD123319, enhanced the severity of AAA [14]. Another study reported that simvastatin prevented the AngII-induced AAA formation in ApoE−/− mice by inhibiting MMP-2 and MMP-9 activity, MCP-1 protein expression, and ERK activity, indicating that inflammatory response and MAPK activation are involved in the pathogenesis of AAA [5].

Curcuma is the source of the spice, turmeric, which is widely used in Asian countries, especially in India and China. A number of scientific evidences have demonstrated that curcumin has many beneficial effects on health, including antioxidative and anti-inflammatory effects. Recent study has demonstrated that curcumin has an important role in prevention and treatment of age-related diseases, such as atherosclerosis, coronary heart disease, diabetes mellitus, and others owing to its powerful antioxidant and anti-inflammatory activities [6, 7]. The common characteristics of age-related disease are a low grade inflammatory response driven by oxygen stress and curcumin is believed to participate in age-related diseases by counteracting the inflammatory state and inhibiting oxygen stress production. Therefore, it has been widely used as a daily health supplement and treatment in cardiovascular disease. It was reported that curcumin protects the endothelial cell activity, inhibits vascular smooth muscle cell (VSMC) proliferation, and decreases the inflammatory response in vascular wall [8]. Quiles et al. found that Curcuma longa reduced oxidative stress production and prohibited the development of fatty streaks in aortic arch, thoracic aorta, and abdominal aorta in rabbits fed a high cholesterol diet [9].

Previous study found that curcumin could inhibit formation of rat aneurysm induced by calcium chloride method [10], but the result from other studies showed that calcium chloride-induced AAA did not reveal atherosclerotic plaque formation, vascular thrombus, and rupture, all of which represents classical features of human AAA [11].

The formation of aneurysm induced by the infusion of AngII has characteristic features that are much more similar to the human disease than other models of aneurysm induced by calcium chloride. The calcium chloride-induced AAA in rat only induces the formation of aneurysm, with no consideration of hyperlipidemia, gender, atherosclerosis, thrombus, rupture, and other complicated factors in human disease, but the aneurysm induced by AngII in ApoE−/− mice generally considers atherosclerosis, thrombus, hyperlipidemia, gender, and rupture, and it is more fit for studying the mechanisms and treatment of AAA [1, 2, 11].

In this study, we established the AAA induced by AngII infusion and then observed the effect of curcumin on the AAA in ApoE−/− mice. We hypothesized that curcumin prevents aneurysm development by inhibiting inflammatory response, MMP activity, and ERK signal pathway activation during AAA formation. We determined the effect of curcumin on the pathogenesis of AAA in ApoE−/− mice. Our results showed that curcumin treatment significantly prevented AAA formation.

2. Materials and Methods

2.1. Ethics Statement

This study conforms to the principles outlined in the Declaration of Helsinki and to Chinese legal dispositions. This experiment was implemented in accordance with the recommendations in the guide for the care and use of laboratory animals published by the People’s Republic of China (document number 55, 2001). All animal procedures were approved by the Committee on the Ethics of Animal Experiments of Shandong University.

2.2. Animal Modal

Male ApoE−/− mice on a C57BL/6J background strain were housed under barrier conditions with food and water. Thirty-six mice (24-week-old male) were randomly divided into 3 groups (, each): AngII alone group (infusion of AngII, 1000 ng/kg/min, Sigma, St. Louis, MO, USA), AngII + Cur group (100 mg/kg/d, Sigma-Aldrich, St. Louis, MO, USA), and control group (infusion of normal saline). The mice were anaesthetized by intraperitoneal injection of ketamine (150 mg/kg) and xylazine (10 mg/kg). Miniosmotic pumps (Alzet Model 2004, Durect Corp, Cupertino, CA, USA) were implanted subcutaneously in mice to deliver AngII (1000 ng/kg/min) or saline for 28 days according to the literature as described previously [5, 8, 12]. Curcumin was dissolved in 1% carboxymethyl cellulose and was applied by daily oral gavage in AngII + Cur group. The curcumin treatment was initiated 1 week before AngII infusion and lasted for 28 days. At the end of experiment, the mice were anesthetized with xylazine 20 mg/kg and ketamine 100 mg/kg and the aortas were isolated for pathology examination.

2.3. Aortic Diameter Measurement and Aneurysms Diagnosis

Following anesthesia with xylazine 20 mg/kg and ketamine 100 mg/kg, the mice were cut open ventrally. Phosphate-buffered saline (PBS) was perfused into left ventricles and exited through the severed auricula dextra. Suprarenal region of abdominal aorta containing AAA was identified between the last pair of intercostal arteries and the right renal branch. After periadventitial tissues were removed from the aortic wall, the aortic wall was photographed and the maximal aortic diameter of the aorta was measured with a caliper. Aneurysms were defined and diagnosed by reference to the previous literature; the aneurysm diagnosis was made when the maximum diameter of the aorta exceeded 50% of the normal diameter.

The average diameter of normal suprarenal aorta in our control mice is ≈0.83 ± 0.04 mm. Therefore, we set a threshold of 1.25 mm as evidence of the incidence of aneurysm formation.

2.4. Specimen Preparation and Staining

The suprarenal region of abdominal aorta containing AAA was perfused with PBS and then either fixed in 10% buffered formalin solution or frozen in liquid nitrogen. For each mouse, one part of abdominal aorta containing AAA was used for histological examination and the other part was used for Western blotting and measurement of the oxidative radical.

The suprarenal aortas used for histological examination were harvested and dehydrated with different gradients of ethanol and then embedded with paraffin. Paraffin-embedded suprarenal aortas were cross-sectioned into pieces 4 μm thick. H&E and Verhoeff Van-Gieson (VVG) staining were performed according to previous routine method.

2.5. Immunohistochemistry

The suprarenal region of abdominal aorta containing AAAs was serially cross-sectioned. The macrophages infiltration, MCP-1, TNF-α, MMP-2, and MMP-9 expression were analyzed by immunohistochemistry as described previously. The primary antibodies were used as follows: macrophages, MCP-1, TNF-α, and ERK1/2 were identified with a rabbit anti-mouse polyclonal antibody (Abcam, USA). MMP-2 and MMP-9 were detected with a monoclonal antibody (1 : 50, Abcam, USA). The cross-sections were labeled with primary antibodies at 4°C overnight. After washing, the bound antibodies were conjugated with secondary antibodies at 37°C for 1 hour, and then the DAB substrate was administrated and incubated for 1-2 minutes. The sections were counterstained with hematoxylin and the result was acquired with image analysis system (Image-Pro Plus 5.0, Media Cybernetics, USA).

2.6. RT-PCR

Total RNA was isolated from abdominal aortas containing AAAs using the TriZol method (Invitrogen, USA) according to the manufacturer’s protocol. The concentration of total RNA was quantified by spectrophotometry and the mRNAs were reverse-transcribed into cDNAs using iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). Quantitative real-time RT-PCR was performed with an Applied Lightcycler2.0 detection system (Roche Applied Science, USA) involving the SYBR-based method in 20 μL reaction volume according to the manufacturer’s instructions. The PCR primers of TNF-α, MCP-1, and β-actin are as follows: TNF-α, 5′-CCTGTAGCCCACGTCGTAGC-3′ and 5′-TTGACCTCAGCGCTGAGTTG-3′; MCP-1, 5′-ACTGAAGCCAGCTCTCTCTTCCTC-3′ and 5′-TTCCTTCTTGGGTCAGCACAGAC-3′; β-actin, 5′-TGCTGTCCCTGTAGTCCTCT-3′ and 5′-AGGTCTTTACGGATGTCAACG-3′. Reaction specificity was demonstrated by analyzing melting curves and by gel electrophoresis of the amplicons. The relative changes in gene expression were analyzed using a comparative method described in the applied biosystems user bulletin. The data were analyzed with method.

2.7. Gelatin Zymography

The MMP-2 and MMP-9 activity were evaluated by methods of zymography according to previous literature [13]. Abdominal aortas containing AAAs were homogenized in a buffer containing 50 mM Tris/HCl (pH 7.5), 150 mM NaCl, and 1% Nonidet P-40. The homogenate was centrifuged and the protein concentration was measured by Bradford assay (Bio-Rad, Philadelphia, USA). 20 μg of protein aliquots was used for each zymographic assay. The experiment of gelatine zymography was carried out under nonreducing conditions on 10% SDS-PAGE gel containing 0.1% (w/v) gelatin at 4°C. The gels were washed with a washing buffer containing 2.5% Triton X-100, incubated in reaction buffer (50 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 5 mM CaCl2, 0.02% NaN3, and 0.05% Brij 35) at 37°C for 48 hours, and then stained with 2.5% Coomassie brilliant blue (Sigma Chemical Co., St. Louis, MO, USA). The band intensity was quantified by computer-assisted image analysis (Image-Pro Plus 5.0, Media Cybernetics, USA).

2.8. Measurements of SOD and MDA Assays

The SOD activity in the aneurysm was measured according to the method using a kit (NJBC, Nanjing, China). Tetrazolium salt can be made to form a red formazan dye by superoxide radicals generated by xanthine oxidase and hypoxanthine. The red formazan dye was measured and evaluated at the optical density at 550 nm by a spectrophotometer. The SOD activity was expressed as U/mg protein.

The MDA contents were measured according to thiobarbituric acid method. The procedure was carried out following the manufacturer’s instruction (NJBC, Nanjing, China). The samples were determined at a wavelength of 546 nm using a spectrophotometer, and the results were expressed in terms of nmol/mg protein.

2.9. Western Blot

ERK1/2 protein expression was detected by Western blot analysis. Mouse abdominal aortas containing AAAs were homogenized in a RIPA lysis buffer (Sigma Chemical Co.) containing protease inhibitors (Roche, Germany) and the total protein was extracted and detected. Twenty micrograms of each protein sample was electrophoresed on 14% SDS-PAGE. The protein was transferred onto a polyvinylidene difluoride (PVDF) membrane for 120 min at 250 mA. Following incubation in blocking solution, membranes were hybridized with 1 : 250 dilution of the primary anti-ERK1/2 antibodies (Santa Cruz Biotechnology, USA) overnight at 4°C. The membranes were then incubated with second antibodies for 60 min at room temperature. The visualization of immune-reactive bands was detected by enhanced chemiluminescence reagent. Quantification of the intensities of each band was performed by use of a MSF-300G Scanner (Microtek Lab, Nikon, Japan).

2.10. Serum Lipids and Blood Pressure Measurement

Serum cholesterol, low-density lipoprotein (LDL), and triglyceride (TG) level were measured by an enzymatic assay kit. The blood pressure was measured on mice using noninvasive tail-cuff systems (BP2010AUL, Softron) in the morning. Considering the procedure-induced anxiety, mice were acclimated to the blood pressure monitor and attemperator (TMC-213, Softron) for three days prior to these measurements. On the 27th day, six blood pressure values were taken on each mouse and averaged for analysis.

2.11. Statistical Analysis

Data analysis involved use of SPSS 11.5. Pearson’s chi-squared test was performed to compare the incidence of aneurysm. One way analysis of variance was used to test the difference of means among three groups for continuous variables. A value was considered statistically significant.

3. Results

3.1. Curcumin Reduced the Incidence and Severity of AngII-Induced AAA Formation in ApoE−/− Mice

To evaluate the effect of curcumin on AngII-stimulated AAA formation, AngII-induced mice were treated with curcumin or vehicle. No aneurysms were present in saline-infused control ApoE−/− mice (). In contrast, the result showed that eleven of 12 (or 92%) of AngII-induced mice developed aortic aneurysms (Figures 1(a) and 1(b)). However, this effect of AngII was statistically decreased in mice treated with curcumin; the result showed that 6 of 12 (or 50%) developed the aortic aneurysms, indicating that curcumin treatment significantly decreased the occurrence of AAA (Figure 1(b)).

There was no statistical difference in the incidence of aneurysm rupture between AngII + Cur group and AngII group (Table 1). The diameter of abdominal aortas in AngII alone group ( mm, ) was significantly higher than that in control group ( mm, , ). In contrast, the administration of curcumin treatment in AngII + Cur group ( mm, , ) significantly decreased the aortic diameter compared to the AngII alone group (Figure 1(c)). The result demonstrated that curcumin treatment obviously attenuated the incidence and protected ApoE−/− mice against AngII-induced AAA formation and development.

Groups Control
AngII + Cur

AAA formation, (%)None11 (92)6 (50)#
AAA rupture, (%)None8 (72.7)4 (66.7)

versus AngII or control group.
3.2. Curcumin Decreased Remodeling of Aortic Wall and Inhibited Inflammatory Response in AngII-Induced AAA

H&E staining from the region of the aorta demonstrated that AngII treatment gives rise to a thickening of the abdominal aortic wall and disruption of the media and adventitia. VVG staining proved the disruption of the elastin fibers in the AngII alone group and AngII + Cur group (Figure 2). However, the adventitial thickness and disruption of the media and adventitia were relatively less marked in AngII + Cur group. There are no intimal thickening and the elastin fibers in control aortas are intact and not disrupted (Figure 2).

The result showed that AngII-infusion not only induced macrophage infiltration, but also increased MCP-1, TNF-α gene, and protein expression as evaluated by RT-PCR (Figures 3(b) and 3(c)) and immunohistochemical staining (Figures 3(a), 3(d), 3(e), and 3(f)). In contrast, the macrophage infiltration, MCP-1, TNF-α gene expression, and protein expression were significantly lower in AngII + Cur group than those in AngII alone group (all ), indicating that curcumin treatment inhibited the inflammatory response in the pathogenesis of AAA.

3.3. Curcumin Inhibited MMP-2 and MMP-9 Expression and Activity

The methods of immunohistochemistry and zymography were used to evaluate the MMP-2 and MMP-9 expression and MMP-2 and MMP-9 activity. The result showed that the staining of MMP-2 and MMP-9 by immunohistochemistry was extensive in AngII group as compared with that of AngII + Cur group (Figure 4(a)). The result also revealed that AngII-infusion in AngII group significantly increased the MMP-2 and MMP-9 activity by zymography (Figures 4(b)4(d)). Conversely, curcumin treatment markedly inhibited MMP-2 and MMP-3 expression and activity in AngII + Cur group (all ).

3.4. Curcumin Diminished ROS and ERK Signaling Pathways

The result showed that the SOD was lower in AngII alone group compared to that of the control group. In contrast, the level of SOD increased in AngII + Cur group as compared with that of AngII alone group (). In addition, the level of MDA was increased in AngII alone group as compared with that in the control group. Furthermore, curcumin treatment reduced the MDA level, and the level of MDA was statistically lower in AngII + Cur group than that in AngII alone group (Table 2, ). To explain the signaling pathways in aortic aneurysm, the ERK1/2 signaling pathways were evaluated. ERK1/2 phosphorylation in AAA of AngII alone group was significantly higher than that in AngII + Cur group (, Figures 5(b) and 5(c)); the result suggested that curcumin attenuated AAA pathogenesis at least by ERK1/2 signaling pathways.

Groups SOD
(U/mg protein)
(nmol/mg protein)

AngII + Cur
AngII74.79 ± 3.819.59 ± 0.61
Control105.54 ± 10.36 1.90 ± 0.22

versus AngII group.
3.5. Blood Pressure and Biological Measurements

Systolic blood pressure was measured in three groups, and the results showed that the systolic blood pressure was significantly higher in AngII alone group and AngII + Cur group than that in control group (), whereas systolic blood pressure was not statistically different between AngII alone group and AngII + Cur group. In addition, there was no significant difference in total cholesterol, LDL, and TG among AngII alone group, AngII + Cur group, and control group (Table 3).


AngII + Cur600.37 ± 53.75163.50 ± 8.67105.79 ± 13.33 605.66 ± 35.12
AngII603.73 ± 31.43169.75 ± 4.43112.84 ± 16.71 607.74 ± 38.27
Control584.41 ± 52.14159.25 ± 8.81110.09 ± 16.66112.39 ± 5.80600.39 ± 15.10

versus control group.

4. Discussion

In the present study, we found that the incidence of AAA was significantly lower in AngII + Cur group than that in AngII alone group. Moreover, we demonstrated that the benefit of curcumin treatment on AAA is associated with the reduction of inflammatory response, decreased MMP-2 and MMP-9 activities, and inhibited ROS production. Furthermore, we reported that curcumin inhibits ERK phosphorylation in AAA.

RAS plays an important role in the pathogenesis of atherosclerosis and AAA. Previous studies have shown that AngII infusion induced AAA formation in ApoE−/− mice. In line with the previous findings, our results demonstrated that AngII infusion increased the rates of AAA formation in ApoE−/− mice. Thus, the AngII-induced AAA offered a good model to investigate the mechanism and pathogenesis of AAA in humans [5, 6, 14, 15].

Inflammation response and the local chronic inflammation of the aortic wall are characterized signs in the pathogenesis of AAAs [1]. Macrophage accumulation in the aortic wall is an early feature of AngII-induced AAAs and it presents in the whole process of AAA.

Our studies found that infusion of AngII induces marked inflammatory responses in the AAA which manifests increased macrophage infiltration and MCP-1 expression. However, curcumin administration inhibited MCP-1 expression and macrophage accumulation. In addition, curcumin also decreased TNF-α and IL-1 protein expression. Previous study also showed that curcumin decreased IL-1 and IL-6 level in C57Bl/6 mice induced AAAs with transient elastase perfusion [16]; the above result indicated that curcumin may prevent the formation of AAA by anti-inflammatory function.

It is well documented that MMPs play an essential role in the pathogenesis of AAA [17, 18]. MMPs are main enzymes that degrade the structural components of the ECM, and the formation and progression of AAA are accompanied by degradation of vascular ECM. Previous studies have shown that MMP activity is elevated in AAA. The level of circulating MMP-9 was significantly higher in patients with AAA than in those without AAA. Moreover, recent study reported that the level of MMP-9 in the plasma was statistically elevated in patients with ruptured AAA, compared to patients with nonruptured AAA [19]. Strikingly, it was reported that the inhibition of MMP activity prevented the development of AAA. Thus, the elevated MMP activity-induced vascular middle layer degradation is critical for the pathogenesis of AAA. In this study, we showed that AngII-infusion significantly increased the activity and expression level of MMP-2 and MMP-9. Conversely, curcumin treatmentsignificantly inhibited activity of MMP-2 and MMP-9. It has been previously shown that the activity of MMPs can be modulated by many inflammatory factors and oxygen radical [20, 21], so we speculated that mechanism of curcumin against MMP-2 and MMP-9 activities may be due to its anti-inflammatory and antioxidant effects. Taken together, these results suggest that one of the mechanisms of curcumin in preventing formation of AAA is by inhibition of activity of MMP-2 and MMP-9.

Increased oxidative stress is another important mechanism in the progression of AAA [22, 23]. It was reported that the production of oxidants is elevated and its antioxidants ability is decreased in AAA. Many studies have shown that curcumin has an important role in its elimination of reactive oxygen species. In this study, we found that the levels of superoxide dismutase (SOD) were significantly decreased, but the levels of malondialdehyde (MDA) were higher in the AngII group than those in AngII + Cur group; the result suggested that curcumin reduces oxidative stress production in AAA.

Oxidative stress can also influence the gene expression of signaling molecules such as MAPK and nuclear factor-κB (NF-κB). The previous study has shown that MAPK activation has been associated with macrophage infiltration in aneurysm and other inflammatory processes and with the activation of MMPs [5, 24]. Administration of CI1040, an inhibitor of ERK activation, attenuated the severity of aneurysm, macrophage infiltration, and MMP expression; the result has demonstrated that MAPK activation plays an important role in the pathogenesis of aneurysm [5]. Fan et al. showed that curcumin attenuates AAA formation by inhibiting JNK phosphorylation [10]. Zhang et al. found that the ERK was highly expressed in AngII-induced AAA formation. Another report found that simvastatin prevents AAA formation by inhibiting ERK phosphorylation [5]. It remains elusive whether curcumin treatment affects ERK phosphorylation in AngII-induced AAA. Our data showed that ERK phosphorylation significantly increased in the AngII group than that in the AngII + Cur group. Thus, our result indicated that curcumin reduces AAA formation at least in part via the inhibition of ERK signaling pathway. Previous study showed that nuclear factor-κB (NF-κB) signaling, the major transcription factor in mediating inflammation, can be activated in aneurysm. Katagiri’s group established the mice model with endothelium transgenic expression of dominant-negative IκBα (E-DNIκB mice) and demonstrated that aneurysm formation is significantly inhibited in E-DNIκB mice; the mechanism refers to inhibition of vascular inflammatory response and matrix metalloproteinases activation [25]. Study by Parodi et al. found that curcumin inhibits the NF-κB activation and reduces the formation of aneurysm [16]. Previous study showed that curcumin attenuates cardiac inflammatory response, inhibits cardiomyocytic apoptosis, inhibits atherosclerosis, and prevents diabetic cardiomyopathy by inhibiting NF-κB activity [26, 27]. From the above study, we speculated that the complex signaling pathway including MAPK and NF-κB, the crosstalk between oxidative stress, and inflammation may be more important factor in the pathogenesis of aneurysms; the effect of curcumin on the treatment of aneurysm may be multiple-targeted including its anti-inflammatory and antioxidant effects by inhibition of multiple signaling pathways, including MAPK and NF-κB signaling pathway.

In summary, our study demonstrated that curcumin significantly reduced the incidence of AngII-induced AAA formation in ApoE−/− mice, and the protective effect of curcumin likely resulted from the reduced inflammatory response, decreased MMP-2 MMP-3 activity, and lowered ROS production. The mechanisms underlying these therapeutic effects involved downregulated ERK and AngII-ROS pathways. Thus, our study provides the new clue that daily use of curcumin is an effective approach to the prevention and treatment of AAA.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The authors would like to express their thanks to Dr. Xu Peng at Department of Medical Physiology, Texas A&M Health Science Center College of Medicine, Texas, USA, and Dr. Shengxian Jia at the Department of Surgery, Northwestern University, Chicago, USA. They also thank Hong Jiang, Xu Ping Wang, ShanYing Huang, FeiFei Xu, and Zhi Yang for their technical assistance. This study was supported by the National 973 Basic Research Program of China (no. 2013CB530700), the National Natural Science Foundation of China (no. 81170207), and the Program of State Chinese Medicine Administration Bureau (no. JDZX2012113).


  1. A. Daugherty, L. A. Cassis, and H. Lu, “Complex pathologies of angiotensin II-induced abdominal aortic aneurysms,” Journal of Zhejiang University: Science B, vol. 12, no. 8, pp. 624–628, 2011. View at: Publisher Site | Google Scholar
  2. A. Daugherty, D. L. Rateri, and L. A. Cassis, “Role of the renin-angiotensin system in the development of abdominal aortic aneurysms in animals and humans,” Annals of the New York Academy of Sciences, vol. 1085, pp. 82–91, 2006. View at: Publisher Site | Google Scholar
  3. H. Lu, D. L. Rateri, L. A. Cassis, and A. Daugherty, “The role of the renin-angiotensin system in aortic aneurysmal diseases,” Current Hypertension Reports, vol. 10, no. 2, pp. 99–106, 2008. View at: Publisher Site | Google Scholar
  4. H. Lu, D. L. Rateri, D. Bruemmer, L. A. Cassis, and A. Daugherty, “Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms,” Clinical Science, vol. 123, no. 9, pp. 531–543, 2012. View at: Publisher Site | Google Scholar
  5. Y. Zhang, J. C. Naggar, C. M. Welzig et al., “Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein e-knockout mice: possible role of ERK,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 11, pp. 1764–1771, 2009. View at: Publisher Site | Google Scholar
  6. E. Sikora, G. Scapagnini, and M. Barbagallo, “Curcumin, inflammation, ageing and age-related diseases,” Immunity & Ageing, vol. 7, article 1, 2010. View at: Publisher Site | Google Scholar
  7. Y. Sunagawa, H. Wada, H. Suzuki et al., “A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats,” Biological and Pharmaceutical Bulletin, vol. 35, no. 2, pp. 139–144, 2012. View at: Publisher Site | Google Scholar
  8. S. K. Jain, J. Rains, J. Croad, B. Larson, and K. Jones, “Curcumin supplementation lowers TNF-α, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-α, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats,” Antioxidants and Redox Signaling, vol. 11, no. 2, pp. 241–249, 2009. View at: Publisher Site | Google Scholar
  9. J. L. Quiles, M. D. Mesa, C. L. Ramírez-Tortosa et al., “Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 7, pp. 1225–1231, 2002. View at: Publisher Site | Google Scholar
  10. J. Fan, X. Li, Y.-W. Yan et al., “Curcumin attenuates rat thoracic aortic aneurysm formation by inhibition of the c-Jun N-terminal kinase pathway and apoptosis,” Nutrition, vol. 28, no. 10, pp. 1068–1074, 2012. View at: Publisher Site | Google Scholar
  11. Y. Wang, S. Krishna, and J. Golledge, “The calcium chloride-induced rodent model of abdominal aortic aneurysm,” Atherosclerosis, vol. 226, no. 1, pp. 29–39, 2013. View at: Publisher Site | Google Scholar
  12. A. Daugherty, M. W. Manning, and L. A. Cassis, “Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice,” The Journal of Clinical Investigation, vol. 105, no. 11, pp. 1605–1612, 2000. View at: Publisher Site | Google Scholar
  13. Z. S. Galis, M. Muszynski, G. K. Sukhova et al., “Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion,” Circulation Research, vol. 75, no. 1, pp. 181–189, 1994. View at: Publisher Site | Google Scholar
  14. J. P. Habashi, J. J. Doyle, T. M. Holm et al., “Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism,” Science, vol. 332, no. 6027, pp. 361–365, 2011. View at: Publisher Site | Google Scholar
  15. A. Daugherty, M. W. Manning, and L. A. Cassis, “Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis,” British Journal of Pharmacology, vol. 134, no. 4, pp. 865–870, 2001. View at: Publisher Site | Google Scholar
  16. F. E. Parodi, D. Mao, T. L. Ennis, M. B. Pagano, and R. W. Thompson, “Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms,” Annals of Vascular Surgery, vol. 20, no. 3, pp. 360–368, 2006. View at: Publisher Site | Google Scholar
  17. X. Zhang, Y. H. Shen, and S. A. LeMaire, “Thoracic aortic dissection: are matrix metalloproteinases involved?” Vascular, vol. 17, no. 3, pp. 147–157, 2009. View at: Publisher Site | Google Scholar
  18. F. Aziz and H. Kuivaniemi, “Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm,” Annals of Vascular Surgery, vol. 21, no. 3, pp. 392–401, 2007. View at: Publisher Site | Google Scholar
  19. H. Takagi, H. Manabe, N. Kawai, S.-N. Goto, and T. Umemoto, “Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-analysis,” Interactive Cardiovascular and Thoracic Surgery, vol. 9, no. 3, pp. 437–440, 2009. View at: Publisher Site | Google Scholar
  20. X. Zhu, Z. Wang, C. Hu, Z. Li, and J. Hu, “Honokiol suppresses TNF-α-induced migration and matrix metalloproteinase expression by blocking NF-κB activation via the ERK signaling pathway in rat aortic smooth muscle cells,” Acta Histochemica, vol. 116, no. 4, pp. 588–595, 2014. View at: Publisher Site | Google Scholar
  21. I. Parastatidis, D. Weiss, G. Joseph, and W. R. Taylor, “Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 10, pp. 2389–2396, 2013. View at: Publisher Site | Google Scholar
  22. C. Aivatidi, G. Vourliotakis, S. Georgopoulos, F. Sigala, E. Bastounis, and E. Papalambros, “Oxidative stress during abdominal aortic aneurysm repair—biomarkers and antioxidant's protective effect: a review,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 3, pp. 245–252, 2011. View at: Google Scholar
  23. R. M. Starke, N. Chalouhi, M. S. Ali et al., “The role of oxidative stress in cerebral aneurysm formation and rupture,” Current Neurovascular Research, vol. 10, no. 3, pp. 247–255, 2013. View at: Google Scholar
  24. M. Cohen, A. Meisser, L. Haenggeli, and P. Bischof, “Involvement of MAPK pathway in TNF-α-induced MMP-9 expression in human trophoblastic cells,” Molecular Human Reproduction, vol. 12, no. 4, pp. 225–232, 2006. View at: Publisher Site | Google Scholar
  25. T. Saito, Y. Hasegawa, Y. Ishigaki et al., “Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation,” Cardiovascular Research, vol. 97, no. 1, pp. 106–114, 2013. View at: Publisher Site | Google Scholar
  26. S. Mito, K. Watanabe, M. Harima et al., “Curcumin ameliorates cardiac inflammation in rats with autoimmune myocarditis,” Biological and Pharmaceutical Bulletin, vol. 34, no. 7, pp. 974–979, 2011. View at: Publisher Site | Google Scholar
  27. V. Soetikno, F. R. Sari, V. Sukumaran et al., “Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway,” European Journal of Pharmaceutical Sciences, vol. 47, no. 3, pp. 604–614, 2012. View at: Publisher Site | Google Scholar

Copyright © 2014 QingQing Hao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.